RB1 and neoplasm: Taken together, in the IHC assay, a total of nine cases (42.9%, 9/21) presented with simultaneous p53/Rb inactivation in the two different tumor components, two cases presented with a simultaneous wild-type expression pattern of p53/Rb, and the remaining ten cases presented with inconsistent expression of p53 and Rb.